- Changes in the Multiple Sclerosis Treatment Paradigm. What Do We Do Now and What Were We Doing Before?
-
Alonso R, Eizaguirre MB, Zavala L, Pita C, Silva B, Garcea O
- KMID: 2424176
- J Clin Neurol.
- 2018 Oct;14(4):487-491.
- doi: 10.3988/jcn.2018.14.4.487
BACKGROUND AND PURPOSE: The number of disease-modifying drugs (DMDs) available for treating relapsing-remitting multiple sclerosis is increasing. Numerous drugs have been approved since 2010 in South America, which has increased... -
- CITED
-
- Close
- SHARE
-
- Close
